Olanzapine Impurity 21 | CAS 612507-13-8 - Request Quote
Olanzapine Impurity 21
| SZ CAT No: | SZ-O001050 |
| CAS No | 612507-13-8 |
| Mol.F. | C12H10N2S2 |
| Mol.Wt. | 246.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Olanzapine Impurity 21 is chemically 2-Methyl-5,10-dihydro-4H-benzo[b]thieno[2,3-e][1,4]diazepine-4-thione. Olanzapine Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Olanzapine Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Olanzapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 612507-13-8
Purchase 612507-13-8
Order 612507-13-8
Enquire 612507-13-8
price of 612507-13-8
612507-13-8 Supplier
612507-13-8 Manufacturer
612507-13-8 Exporter
buy high quality Olanzapine Impurity 21
Purchase Olanzapine Impurity 21
Olanzapine Impurity 21 suppliers
Olanzapine Impurity 21 manufacturers
Olanzapine Impurity 21 price
Order Olanzapine Impurity 21
Enquire Olanzapine Impurity 21
Olanzapine Impurity 21 cost
Olanzapine Impurity 21 Supplier
Olanzapine Impurity 21 Distributor
Olanzapine Impurity 21 for Method Validation
Olanzapine Reference Standard
Olanzapine Impurity 21 for ANDA Filing
Olanzapine Impurity 21 for Forced Degradation Studies
Olanzapine Impurity 21 Identification Standards
Olanzapine Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.